Combined treatment with hyaluronan inhibitor Pep-1 and a selective adenosine A2 receptor agonist reduces inflammation in experimental arthritis

Innate Immunity

Volumn 19, Issue 5, 2013, Pages 462-478

  Campo, Giuseppe M ^a   Avenoso, Angela ^a   D'Ascola, Angela ^a   Nastasi, Giancarlo ^a   Micali, Antonio ^a   Puzzolo, Domenico ^a   Pisani, Antonina ^a   Prestipino, Vera ^a   Scuruchi, Michele ^a   Calatroni, Alberto ^a   Campo, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

adenosine; arthritis; CD44; cytokines; hyaluronan; NF kB; Toll like receptors

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 ANILINOADENOSINE; ANTIRHEUMATIC AGENT; COLLAGEN TYPE 2; COLLAGENASE 3; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 1BETA; MESSENGER RNA; PEP 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DRUG EFFECT; MALE; MICROSCOPY; MOLECULAR SIZE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SYNOVIAL FLUID LEVEL; TREATMENT DURATION; UPREGULATION;

ADENOSINE; ARTHRITIS; CD44; CYTOKINES; HYALURONAN; NF-KB; TOLL-LIKE RECEPTORS;

ADENOSINE; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; ANTIGENS, CD44; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; HYALURONIC ACID; INFLAMMATION MEDIATORS; JOINTS; MALE; MATRIX METALLOPROTEINASE 13; MICE; MICE, INBRED DBA; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES; PROTEOLYSIS; RECEPTOR, ADENOSINE A2B; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84884364040     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912470391     Document Type: Article

References (45)

1. Goldring MB, Marku KB. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther. 2009 ; 11: 224-224
2. Ospelt C, Gay S. The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol. 2008 ; 22: 239-252 (Pubitemid 351606943)
3. Maquart FX, Bellon G, Pasco S, Monboisse JC. Matrikines in the regulation of extracellular matrix degradation. Biochimie. 2005 ; 87: 353-360 (Pubitemid 40387614)
4. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011 ; 91: 221-264
5. Adair-Kirk TL, Senior SM. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol. 2008 ; 40: 1101-1110
6. Powell JD, Horton MR. Threat matrix: low-molecular-weight hyaluronan as a danger signal. Immunol Res. 2005 ; 22: 207-218 (Pubitemid 40628958)
7. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006 ; 85: 699-715 (Pubitemid 44070579)
8. Sironen RK, Tammi M, Tammi R, auvinen PK, Anttila M, Kosma VM. Hyaluronan in human malignancies. Exp Cell Res. 2001 ; 317: 383-391
9. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002 ; 21: 25-29 (Pubitemid 34100819)
10. Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Prestipino V, Nastasi A, et al. The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis. J Cell Biochem. 2012 ; 113: 1852-1867
11. Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, et al. Inhibition of hyaluronan synthesis reduced inflammatory response in mouse synovial fibroblasts subjected to collagen-induced arthritis. Arch Biochem Biophys. 2012 ; 518: 42-52
12. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990 ; 61: 1303-1313
13. Heldin P, Karousou E, Bernert B, Porsch H, Nishitsuka K, Skandalis SS. Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis. Connect Tissue Res. 2008 ; 49: 215-218
14. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury though TLR4. J Biol Chem. 2004 ; 279: 17079-17084 (Pubitemid 38560463)
15. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005 ; 11: 1173-1179 (Pubitemid 43093664)
16. Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Calatroni A. Differential effect of molecular size HA in mouse chondrocytes stimulated with PMA. Biochim Biophys Acta. 2009 ; 1790: 1353-1367
17. Campo GM, Avenoso A, Campo S, D'Ascola A, Nastasi G, Calatroni A. Small hyaluronan oligosaccharides induce inflammation by both toll-like-4 and CD44 receptors in human chondrocytes. Biochem Pharmacol. 2010 ; 80: 480-490
18. Campo GM, Avenoso A, Nastasi G, Micali A, Prestipino V, Vaccaro M, et al. Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochim Biophys Acta. 2011 ; 1812: 1170-1181
19. Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, et al. Protein Kinase A mediate danti-inflammatory effects exerted by adenosine treatment in mouse chondrocytes stimulated with IL-1β. Biofactors Epub ahead of print 25 October 2012.
20. Fredholm BB, Arsina G, Halldner L, Kull B, Sculte G, Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol. 2000 ; 362: 364-374
21. Milne GR, Palmer TM. Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor. Scientific World Journal. 2011 ; 11: 320-339
22. Sullivan GW, Linden J, Buster BL, Scheld WM. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis. 1999 ; 180: 1550-1560 (Pubitemid 29506457)
23. Sullivan GW. Adenosine A2A receptor agonists as anti-inflammatory agents. Curr Opin Investig Drugs. 2003 ; 4: 1313-1319 (Pubitemid 38100576)
24. Lappas CM, Sullivan GW, Linden J. Adenosine A2A agonists in development for the treatment of inflammation. Expert Opin Investig Drugs. 2005 ; 14: 797-806 (Pubitemid 41030948)
25. Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, et al. The stimulation of adenosine 2A receptor reduces inflammatory response in mouse articular chondrocytes treated with hyaluronan oligosaccharides. Matrix Biol. Epub ahead of print 13 July 2012.
26. Mistry D. Chambers MG and Mason RM, The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line. Osteoarthritis Cartilage. 2006 ; 14: 486-495
27. Manera C, Saccomanni G. A2A receptor ligands: past, present and future trends. Curr Top Med Chem. 2010 ; 10: 902-922
28. Takahashi N, Tetsuka T, Uranishi H, Okamoto T. Inhibition of the NF-kB transcriptional activity by protein kinase A. Eur J Biochem. 2002 ; 269: 4559-4565
29. Mazzon E, Esposito E, Impellizzeri DD, Di Paola R, Melani A, Bramanti P, et al. CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of muryne type II collagen-induced arthritis. J Rheumatol. 2011 ; 38: 2119-2129
30. Mummert ME, Mohamadzadeh M, Mummert DI, Mizumoto N, Takashima A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med. 2000 ; 192: 769-779
31. Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Prestipino V, Nastasi G, et al. Adenosine A2A receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin-1β. FEBS J. 2012 ; 279: 2120-2133
32. Gao F, Cao M, Yang C, He Y, Liu Y. Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study. J Biomed Mater Res B Appl Biomater. 2006 ; 78: 385-392 (Pubitemid 44167744)
33. Minenkova O, Pucci A, Pavoni E, De Tomassi A, Fortugno P, Gargano N, et al. Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer. 2003 ; 106: 534-544 (Pubitemid 36966210)
34. Han MJ, Cimen H, Miller-Lee JL, Koc H, Koc EC. Purification of human mitochondrial ribosomal L7/L12 stalk proteins and reconstitution of functional hybrid ribosomes in Escherichia coli. Protein Expr Purif. 2011 ; 78: 48-54
35. Lee HG, Cowman MK. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem. 1994 ; 219: 278-287 (Pubitemid 24206807)
36. Bhiloca S, Amin R, Pandya M, Yuan H, Tank M, Lo Bello J, et al. Agarose and polyacrilylamide gel electrophoresis methods for molecular mass analysis of 5 to 500 kDa hyaluronan. Anal Biochem. 2011 ; 417: 41-49
37. Cowman MK, Chen CC, Pandya M, Yuan H, Ramkishun D, LoBello J, et al. Improved agarose gel electrophoresis method and molecular mass calculation for high molecular mass hyaluronan. Anal Biochem. 2011 ; 417: 50-56
38. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 ; 72: 248-254
39. Weissmann G. The pathogenesis of rheumatoid arthritis. Bull NYU Hosp Joint Dis. 2006 ; 64: 12-15 (Pubitemid 44625527)
40. Joseph A, Brasinton R, Kahl L, Ranganathan P, Cheng TP, Atkinson J. Immunologic rheumatic disorders. J Allergy Clin Immunol. 2010 ; 125: 204-215
41. Goldring MB. Updates on high throughput molecular profiling for the study of rheumatoid arthritis. J Cell Physiol. 2007 ; 213: 626-634
42. Senolt L, Vencovsky J, Pavelka K, Ospelt C, Gay S. Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev. 2009 ; 9: 102-107
43. Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007 ; 14: 1315-1323 (Pubitemid 46965261)
44. Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, et al. Hyaluronan differently modulates TLR-4 and the inflammatory response in mouse chondrocytes. Biofactors. 2012 ; 38: 69-76
45. Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Prestipino V, Calatroni A, et al. Hyaluronan in part mediates IL-1β-induced inflammation in mouse chondrocytes by up-regulating CD44 receptors. Gene. 2012 ; 494: 24-35